𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transforming growth factor β1, insulin and prostaglandin E1 enhance prostaglandin F2α mitogenic action in Swiss 3T3 cells via separate events

✍ Scribed by Maria Gomez de Alzaga; Mercedes Goin; Marcela Ortiz; Luis Jimenez de Asua

Book ID
115929646
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
394 KB
Volume
356
Category
Article
ISSN
0014-5793

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Transforming growth factor β1 augments m
Transforming growth factor β1 augments mitogen-induced prostaglandin synthesis and expression of the TIS10/prostaglandin synthase 2 gene both in swiss 3T3 cells and in murine embryo fibroblasts
✍ Rebecca S. Gilbert; Srinivasa T. Reddy; Dr. Dean A. Kujubu; Weilin Xie; Dr. Stev 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1010 KB

## Abstract Transforming growth factor‐beta (TGF‐beta), a potent cytokine, modulates a wide variety of biological responses. Among its actions, TGF‐beta can augment prostaglandin synthesis in several cell types. Although TGF‐beta alone has no effect on prostaglandin production in Swiss 3T3 cells, w

Mevalonate dependency of the early cell
Mevalonate dependency of the early cell cycle mitogenic response to epidermal growth factor and prostaglandin F2α in Swiss mouse 3T3 cells
✍ Marcela B. Ortiz; Mercedes Goin; Maria B. Gomez de Alzaga; Swen Hammarstrom; Lui 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 778 KB

Lovastatin (LOV), a hydroxy-methylglutaryl-coenzyme A (HMGCoA) reductase competitive inhibitor, blocks epidermal growth factor (EGF)or prostaglandin F , , (PGF,,)-induced mitogenesis in confluent resting Swiss 3T3 cells. This inhibition occurs even in the presence of insulin, which potentiates the a